This study examines the safety of pregabalin over a 6 month period in patients with
neuropathic pain associated with HIV infection as an extension of another trial that tests
the efficacy of pregabalin.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.